Rising diagnosis of rare diseases is a key driver accelerating growth in the Angina Pectoris Drugs Market due to improved genetic testing

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Angioedema Treatment Market From 2026 To 2030?

The angioedema treatment market has experienced rapid expansion in its size over recent years. Its valuation is projected to rise from $3.13 billion in 2025 to $3.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. Historically, this expansion can be linked to factors such as emergency allergy management, hospital-based care, the application of corticosteroids, the presence of antihistamines, and a scarcity of targeted drug options.

The angioedema treatment market size is projected to experience substantial growth over the next few years, with an anticipated increase to $6.18 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.5%. This growth in the forecast period is expected to be driven by advancements in biologic drug development, the expansion of genetic testing, the proliferation of specialty allergy clinics, improved patient education, and a heightened focus on preventive care. Significant trends for the forecast period include the increased utilization of targeted bradykinin therapies, the development of hereditary angioedema treatments, the broadening of emergency treatment protocols, enhanced diagnostic awareness, and a sustained emphasis on preventive therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

What Key Drivers Are Influencing The Growth Of The Angioedema Treatment Market?

The angioedema treatment market is projected to expand due to an increasing occurrence of rare diseases. These are health conditions impacting a small segment of the populace, frequently associated with few therapeutic choices and substantial health consequences. The heightened prevalence of rare diseases stems from innovations in genetic testing and diagnostic methods, which allow medical experts to identify and precisely diagnose conditions previously undiagnosed. Angioedema treatment plays a crucial role in managing rare diseases like hereditary angioedema, offering specific therapies to prevent and control acute swelling episodes, thereby enhancing patient results. For example, data from the US-based federal agency, the Food and Drug Administration, indicated that by November 2024, over 7,000 rare diseases affected more than 30 million individuals in the United States. Consequently, the growing frequency of rare diseases is a key factor propelling the expansion of the angioedema treatment market.

Which Segments Are Included In The Analysis Of The Angioedema Treatment Market?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

Subsegments:

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

Which Trends Are Impacting The Growth Of The Angioedema Treatment Market?

Leading companies within the angioedema treatment market are concentrating on creating advanced solutions, including subcutaneous injections, to provide patients experiencing acute hereditary angioedema (HAE) attacks with more convenient and quicker relief. Subcutaneous injections involve a technique where medication is administered into the fatty layer directly under the skin, facilitating its gradual and consistent absorption into the bloodstream. An illustrative example is CSL Limited, an Australia-based biotechnology company, which introduced ANDEMBRY (garadacimab) in April 2025. This product serves as a new, fully human monoclonal antibody therapy designed to prevent acute attacks in individuals with hereditary angioedema (HAE). Notably, ANDEMBRY stands as the inaugural pre-filled pen designed for once-monthly subcutaneous delivery, presenting an accessible long-term prophylactic alternative. Its mechanism involves inhibiting activated Factor XII (Factor XIIa), a crucial initiator in the biochemical sequence that results in angioedema. This marks a substantial progression in HAE management, delivering effective, patient-focused disease control.

Which Key Industry Participants Are Active In The Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Read the full angioedema treatment market report here:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2025. The regions covered in the angioedema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Angioedema Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

Browse Through More Reports Similar to the Global Angioedema Treatment Market 2026, By The Business Research Company

Hereditary Angioedema Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report

Retinal Vein Occlusion Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-treatment-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795